期刊文献+

CA125联合血浆纤维蛋白原检测在降低卵巢癌误诊率中的意义 被引量:6

Significance of Detecting Fibrinogen Combined with CA125 in Reducing Misdiagnosis of Ovarian Cancer
原文传递
导出
摘要 目的:探讨提高卵巢癌诊断率的更好检测指标。方法:测定并比较82例卵巢癌与75例卵巢巧克力囊肿患者的血小板计数(PLT)、血清CA125及血浆纤维蛋白原(FIB)水平。结果:82例卵巢癌患者PLT、血清CA125及FIB水平均较卵巢巧克力囊肿患者明显升高(P<0.01),卵巢癌患者血浆FIB水平与CA125呈正相关(P<0.01),联用CA125和FIB时阳性预测值明显高于单用CA125检测及联用CA125,PLT二联检测的阳性预测值,略低于联用CA125,FIB,PLT三联检测阳性预测值,而阴性预测值最高。结论:卵巢癌患者体内存在着异常的血液高凝与继发纤溶状态,FIB升高可能与卵巢包块的良恶性及预后有关,联用CA125和FIB检测能提高卵巢癌的诊断率,降低误诊率。 Objective:To study the variation of CA125 and fibrinogen in patients with ovarian cancer or chocolate cyst of ovary,and to explore its clinical significance.Methods:The levels of platelet count,serum CA125 and plasma fibrinogen were determined in 82 cases of ovarian cancer and 75 cases of chocolate cyst of ovary.Results:There were significantly increases about platelet count,CA125,and fibrinogen values in patients with ovarian caner than those of chocolatecyst of ovary(P〈0.01).The level of fibrinogen positively correlated with CA125 in the patients of ovarian cancer(P〈0.01).The positive predictive value in combination of CA125 and fibrinogen was significantly higher than CA125 alone or combination of CA125 and platelet count.But it was slightly lower than combination of CA125,platelet count and fibrinogen.Nevertheless the negative predictive value in combination of CA125 and fibrinogen was the highest in them.Conclusions:There exists an abnormal balance between hyper-coagulation and secondary increased fibrinolytic activity in patients of ovarian cancer.The measurement of fibrinogen is probably beneficial to differentiate benign ovarian tumor from malignancies and to predict its prognosis.The correct diagnostic rate of ovarian cancer before operation can be improved through evaluating with CA125 and fibrinogen together.
出处 《中国误诊学杂志》 CAS 2009年第13期3028-3030,共3页 Chinese Journal of Misdiagnostics
关键词 卵巢肿瘤/诊断 CA-125抗原/血液 纤维蛋白原/分析 人类 女(雌)性 Ovarian Neoplasms/diagnosis CA-125 Antigen/blood Fibrinogen/analysis Humans Female
  • 相关文献

参考文献4

  • 1Greenlee RT,Murray T,Bolden S,et al. Cancer statistics[J]. CA Cancer J Clin,2000,50:7-33.
  • 2Jacobs I,Bast RC. The CA125 tumour-associate antigen: a review of the literature[J]. Hum Reprod, 1989,4:1-12.
  • 3Zacharski LR,Memoli VA,Ornstein DL,et al. Tumor ceil proco agulant and urokinase expression in carcinoma of the ovary[J]. J Natl Cancer Inst,1993,85:1225- 1230.
  • 4Ma Y,Qian Y, Lv W. The correlation between plasma fibrinogen levels and the clinical features of patients with ovarian carcinoma [J]. J Int Med Res,2007,35(5):678-684.

同被引文献61

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部